Europe

NIHR and MRC fund cystic fibrosis gene therapy trial

Wednesday, March 21, 2012 11:08 AM

A groundbreaking gene therapy trial for cystic fibrosis (CF) will begin in March, thanks to a $4.9 million grant from National Institute for Health Research (NIHR) and the Medical Research Council (MRC) through the Efficacy and Mechanism Evaluation program.

More... »

Orexo focuses its business and reduces costs

Friday, March 16, 2012 12:10 PM

Uppsala, Sweden-based Orexo is focusing its development activities to the three proprietary programs OX219, OX51 and OX27, cutting 35 full-time employees in the process.

More... »

Delcath selects Quintiles to support EU launch of Chemosat

Wednesday, March 14, 2012 04:47 PM

Delcath Systems, an ongology-focused pharmaceutical company, has selected Quintiles to provide a specialized team of Medical Science Liaisons (MSLs) to support the launch of the Hepatic Chemosat Delivery System for the treatment of cancers in the liver in France, Germany, Italy, Netherlands, Spain, Ireland and the U.K. 

More... »

New U.K. strategy funds research training for allied health professionals

Wednesday, March 14, 2012 11:57 AM

More research training will be offered to nurses, midwives and allied health professionals thanks to the new Clinical Academic Careers Training Pathway Strategy launched by U.K. Health Secretary Andrew Lansley.

More... »

inVentiv's iHCE establishes headquarters in London

Wednesday, March 14, 2012 11:01 AM

Switzerland-based inVentiv Health Communications/Europe (iHCE), an inVentiv Health company, is opening its new operational headquarters in London to serve as a hub for all European offices and support the rapid growth of the company’s consolidated communications business.

More... »

GSK launches U.K. apprenticeship program

Wednesday, March 14, 2012 10:37 AM

GlaxoSmithKline (GSK) has launched a new multidisciplinary apprenticeship program aimed at 16- to 24-year-olds, offering positions at the company’s U.K. manufacturing, R&D and corporate sites.

More... »

Creabilis begins phase IIb trial of CT327 in psoriasis

Wednesday, March 14, 2012 09:25 AM

Creabilis, a European biotechnology company specializing in dermatology, inflammation and pain, has initiated a phase IIb global clinical trial of its lead product CT327 in patients with psoriasis vulgaris.

More... »

IMI creates platform to discover novel medicines

Monday, March 12, 2012 02:04 PM

In an effort to speed up the discovery of new medicines, the Innovative Medicines Initiative (IMI) has created the European Lead Factory, a Europe-wide public-private partnership that combines the Joint European Compound Collection, a comprehensive collection of candidate drug molecules, with an industry-like screening center.

More... »

Molecular Profiles invests $14.3 million in new facility in Nottingham

Tuesday, March 6, 2012 06:00 AM

Molecular Profiles, a contract research and manufacturing organization, has begun construction of a new manufacturing facility in Nottingham, U.K.

More... »

PRECOS appoints Dr. Martin Page scientific consultant

Thursday, March 1, 2012 06:04 AM

Preclinical Oncology Services Limited (PRECOS), a preclinical R&D service provider with a focus on oncology, has appointed Dr. Martin Page scientific consultant.

More... »